Quick Answer
VYCOR MEDICAL INC reported Cash and Equivalents of $87.0 thousand for fiscal year 2025.
VYCOR MEDICAL INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $87.0K | -17.7% |
| 2024 | $105.6K | +84.4% |
| 2023 | $57.3K | +54.7% |
| 2022 | $37.0K | -59.3% |
| 2021 | $90.9K | +97.7% |
| 2020 | $46.0K | -24.2% |
| 2019 | $60.7K | -29.8% |
| 2018 | $86.5K | -58.1% |
| 2017 | $206.2K | +262.7% |
| 2016 | $56.9K | -83.6% |
| 2015 | $347.5K | -81.6% |
| 2014 | $1.89M | +5943.1% |
| 2013 | $31.3K | -47.7% |
| 2012 | $59.8K | -93.7% |
| 2011 | $950.8K | +648.2% |
| 2010 | $127.1K | +895.1% |
| 2009 | $12.8K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $64.2K | -59.3% | -35.6% |
| June 30, 2025 | $99.7K | -16.4% | +63.3% |
| March 31, 2025 | $61.0K | +39.2% | -42.2% |
| December 31, 2024 | $105.6K | +84.4% | -33.0% |
| September 30, 2024 | $157.6K | +128.3% | +32.1% |
| June 30, 2024 | $119.3K | +123.4% | +172.0% |
| March 31, 2024 | $43.9K | -8.3% | -23.4% |
| December 31, 2023 | $57.3K | +54.7% | -17.0% |
- VYCOR MEDICAL INC showed a decrease of -17.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, VYCOR MEDICAL INC’s cash and equivalents has grown by 581.1% (from $12.8 thousand to $87.0 thousand).
- The most recent figure is from VYCOR MEDICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: